3.57

0.56% 0.02

Third Harmonic Bio Inc (THRD)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$3.55

Offen:

$3.4

24-Stunden-Volumen:

375.15K

Relative Volume:

0.64

Marktkapitalisierung:

$161.02M

Einnahmen:

Nettoeinkommen (Verlust:

$-32.74M

KGV:

-4.3537

EPS:

-0.82

Netto-Cashflow:

$-24.89M

1W Leistung:

+2.29%

1M Leistung:

+3.78%

6M Leistung:

-71.19%

1J Leistung:

-61.65%

1-Tages-Spanne:

$3.3901

$3.60

1-Wochen-Bereich:

$3.33

$3.60

52-Wochen-Spanne:

$3.18

$16.94

Third Harmonic Bio Inc Stock (THRD) Company Profile

Firmenname

Third Harmonic Bio Inc

Sektor

Healthcare (1163)

Branche

Biotechnology (678)

Telefon

(209) 727-2457

Adresse

1700 MONTGOMERY STREET, SAN FRANCISCO

Mitarbeiter

Twitter

Nächster Verdiensttermin

2025-03-26

Neueste SEC-Einreichungen

THRD's Discussions on Twitter

Vergleichen Sie THRD mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
THRD Third Harmonic Bio Inc	3.57	161.02M	0	-32.74M	-24.89M	-0.82
VRTX Vertex Pharmaceuticals Inc	484.01	124.29B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	610.64	66.76B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	590.06	35.99B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	262.16	33.93B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	264.32	28.47B	3.81B	-644.79M	-669.77M	-6.24

Third Harmonic Bio Inc Stock (THRD) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-03-28	Herabstufung	Stifel	Buy → Hold
2025-02-12	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2025-02-11	Herabstufung	Raymond James	Outperform → Mkt Perform
2024-08-09	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2024-06-18	Eingeleitet	Stifel	Buy
2024-06-07	Eingeleitet	Raymond James	Outperform
2022-12-16	Herabstufung	Jefferies	Buy → Hold
2022-12-15	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-10-10	Eingeleitet	Cowen	Outperform
2022-10-10	Eingeleitet	Jefferies	Buy
2022-10-10	Eingeleitet	Morgan Stanley	Overweight

Alle ansehen

Third Harmonic Bio Inc Aktie (THRD) Neueste Nachrichten

Apr 01, 2025

Fierce Biotech Layoff Tracker 2025: Sail cuts staff; Carisma and Inspirna shutter - Fierce Biotech

Apr 01, 2025

Mar 31, 2025

Third Harmonic Bio initiates process to identify opportunities to maximize value - TipRanks

Mar 31, 2025

Layoff Tracker: Arbutus Cuts 57% of Workforce - BioSpace

Mar 31, 2025

Mar 29, 2025

Hold Rating for Third Harmonic Bio, Inc. Amid Strategic Exploration and Cautious Development Approach - TipRanks

Mar 29, 2025

Stifel Downgrades Third Harmonic Bio (THRD) - MSN

Mar 29, 2025

Mar 28, 2025

Stifel Nicolaus Downgrades Third Harmonic Bio to Neutral From Buy, Adjusts Price Target to $5 From $23 - MarketScreener

Mar 28, 2025

Third Harmonic Bio Reports 2024 Financial Results and Strategic Plans - TipRanks

Mar 28, 2025

Mar 27, 2025

Third Harmonic Bio reports FY24 EPS ($1.09) vs. (78c) last year - TipRanks

Mar 27, 2025

Stifel cuts Third Harmonic stock rating to hold, slashes target to $5 - Investing.com

Mar 27, 2025

Third Harmonic Bio Q4 Net Income USD -13.1 Million - Marketscreener.com

Mar 27, 2025

Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results - The Manila Times

Mar 27, 2025

Third Harmonic Bio, Inc. Announces Rise In Full Year Profit - Nasdaq

Mar 27, 2025

Third Harmonic's $285M War Chest Powers Phase 2 CSU Drug Development Amid Strategic Shift - Stock Titan

Mar 27, 2025

Mar 21, 2025

Third Harmonic Bio Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView

Mar 21, 2025

Mar 19, 2025